Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Dow
Boehringer Ingelheim
Federal Trade Commission
UBS
Cantor Fitzgerald
Medtronic
US Army
Citi
Argus Health

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,534,534

« Back to Dashboard

Summary for Patent: 5,534,534
Title: Pharmaceutical compositions for oral use and method of preparing them
Abstract:A pharmaceutical composition for oral use comprising an effective amount of a compound of the formula (I) having antagonistic action to angiotensin II ##STR1## (wherein the ring W is an optionally substituted N-containing heterocyclic residue; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a direct bond or a spacer having an atomic length of two or less between the phenylene group and the phenyl group; and n is an integer of 1 or 2) and an oily substance having a lower melting point, and a method for preparing a pharmaceutical composition for oral use comprising an effective amount of a compound of the formula (I) and an oily substance having a lower melting point, which comprises admixing the compound of the formula (I) with an oily substance having a lower melting point and then subjecting the mixture to molding.
Inventor(s): Makino; Tadashi (Osaka, JP), Mizukami; Yashio (Osaka, JP), Kikuta; Jun-ichi (Osaka, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:07/978,290
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 5,534,534

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,534,534

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-304924Nov 20, 1991

International Patents Family Members for US Patent 5,534,534

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 157248 ➤ Try a Free Trial
Austria 277602 ➤ Try a Free Trial
Australia 2839192 ➤ Try a Free Trial
Australia 659691 ➤ Try a Free Trial
Brazil 1100336 ➤ Try a Free Trial
Canada 2083305 ➤ Try a Free Trial
China 1044088 ➤ Try a Free Trial
China 1047518 ➤ Try a Free Trial
China 1072338 ➤ Try a Free Trial
China 1086998 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Citi
Chubb
Johnson and Johnson
Moodys
Cerilliant
McKinsey
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot